Biondvax Pharmaceuticals Ltd - ADR

NASDAQ:BVXV   10:23:23 AM EDT
0.78
+0.02 (+3.24%)
Earnings Announcements

BiondVax Posts Qtrly Loss Per Share NIS 0.02

Published: 08/25/2022 11:37 GMT
Biondvax Pharmaceuticals Ltd - ADR (BVXV) - Biondvax Announces Second Quarter 2022 Financial Results and Provides Business Update.
Biondvax Pharmaceuticals Ltd - As of June 30, 2022, Biondvax Had Cash and Cash Equivalents of Nis 39.5 Million ($11.3 Million).
Biondvax Pharmaceuticals Ltd - Qtrly Loss per Share Nis 0.02.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.01

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.01

More details on our Analysts Page.